Brazil · Delayed Price · Currency is BRL MBRF Global Foods Company Earnings Call Transcripts
Fiscal Year 2025
-
Record 2025 results with BRL 164B revenue and strong growth in South America and BRF segments. Despite margin pressure in North America, robust demand, capacity expansion, and synergy capture support a positive 2026 outlook.
-
Q3 2025 saw record EBITDA and net income, driven by strong international operations, processed food growth, and successful merger synergies. Market diversification and sustainability initiatives mitigated risks from avian flu and export restrictions, while capital discipline and expanded buybacks supported shareholder value.
-
Q2 2025 delivered 8.6% revenue growth and improved margins, with strong South America and BRF performance offsetting North America margin pressure. The Marfrig-BRF merger is on track, with synergy capture and financial discipline as key priorities.
-
Q1 2025 saw 27% revenue growth and improved margins, with strong South American and BRF performance offsetting North American margin pressure. The proposed Marfrig-BRF merger aims for BRL 805 million in annual synergies and significant tax benefits, creating a global multi-protein leader.
Fiscal Year 2024
-
Q4 2024 saw 22% revenue growth and a 59% rise in adjusted EBITDA year-over-year, with strong South American performance and reduced leverage. Dividend yield reached 29.8%, and capital allocation focused on debt reduction and operational efficiency.
-
Q3 2024 saw 12.4% revenue growth and a 60% rise in adjusted EBITDA, with net income turning positive. Leverage improved, a BRL 2.5 billion dividend was approved, and strong performance was seen across all segments, supported by robust demand and operational efficiency.
-
Q2 2024 saw 16.5% revenue growth and a 64.8% EBITDA increase, with net income turning positive. North America faced margin pressure, while South America and BRF drove strong results. Deleveraging continues, and BRF may pay dividends in November.